Dr. Phil Hariram's Health Blog

Image via Wikipedia At the American College of Rheumatology Congress, reassuring information was released on repeat treatment of rheumatoid arthritis by MabThera or Rituxan (rituxmab). Further improvement of quality of life was achieved by a second course of rituximab. Professor Keystone, University of Toronto, Canada said, “With further analyses, we are able to evaluate just [...]

Patients with Rheumatoid Arthritis should benefit from the new range of drugs called Tumour Necrotic Factor Inhibitors (Anti-TNF). Tests on three of these new drugs slowed progression and reduced symptoms by up to 50%. Research at the Medical University of Vienna, Austria, has shown that these three drugs are most effective in combination with the [...]